Some meta-analyses have reported that certain TGF-β1 polymorphisms (+869C/T and −509C/T) promote susceptibility to HCC [33–36], but clinical significance and prognostic value of TGF-β1 expression in HCC has remained uncharacterized. Here, TGFB1 is linked to hepatocellular carcinoma.